Breaking News Instant updates and real-time market news.

REGN

Regeneron

$310.49

-8.06 (-2.53%)

12:15
07/05/19
07/05
12:15
07/05/19
12:15

Regeneron put volume heavy and directionally bearish

Bearish flow noted in Regeneron with 3,335 puts trading, or 3x expected. Most active are Aug-19 240 puts and Aug-19 235 puts, with total volume in those strikes near 850 contracts. The Put/Call Ratio is 1.59, while ATM IV is up over 2 points on the day. Earnings are expected on August 1st.

  • 09

    Sep

REGN Regeneron
$310.49

-8.06 (-2.53%)

06/21/19
JEFF
06/21/19
NO CHANGE
JEFF
Buy
Jefferies reiterates Buy on AnaptysBio, says Regeneron data 'best case'
Jefferies analyst Biren Amin says that while the selloff this morning in AnaptysBio (ANAB) shares suggests that its etokimab has lower odds after Regeneron's (REGN) REGN3500 data, the data from Regeneron are actually a "best case scenario." The combo of REGN3500 and Dupixent did not offer any additional benefit, says the analyst, who viewed that arm as the greatest long-term risk to etokimab. Also, not all antibodies are built the same, Amin tells investors in a research note titled "Don't Throw The Baby Out With Bathwater; A Lesson To Be Learned From AMG-317." He notes that AMG-317 failed in asthma, and targets IL-4, and yet Dupixent has seen success. The analyst reiterates a Buy rating on AnaptysBio and awaits the company's data in the second half of the year. The stock in early trading is down 15%, or $9.82, to $57.20.
06/21/19
STFL
06/21/19
DOWNGRADE
Target $74
STFL
Hold
AnaptysBio downgraded to Hold from Buy at Stifel
Stifel analyst Derek Archila downgraded AnaptysBio (ANAB) to Hold from Buy as he is less confident etokimab will be meaningfully differentiated from Sanofi (SNY) and Regeneron's (REGN) Dupixent after the latter companies reported results from their Phase 2 study for REGN3500, an antiIL-33 antibody, in asthma. REGN3500 did numerically worse than Dupixent as a monotherapy and the combination of REGN3500/Dupixent did not confer a benefit over Dupixent alone, noted Archila. He lowered his view on the odds of success for etokimab to 50% from 55% and also cut his market share assumptions following the competitors' data. Archila cut his price target on AnaptysBio shares to $74 from $124.
06/18/19
06/18/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. InterContinental (IHG) downgraded to Underweight from Equal Weight at Barclays with analyst Vicki Stern stating downside risks from a macroeconomic slowdown are not reflected in the stock at current valuation levels. 2. Freshpet (FRPT) downgraded to Hold from Buy at SunTrust with analyst William Chappell saying his positive view of the company's fundamental story and outlook have not changed, but he cannot recommend for new investors to buy the stock at its current levels. 3. Regeneron (REGN) downgraded to Hold from Buy at Argus with analyst Jasper Hellweg noting that while the company has a "strong pipeline" with new recent indications for multiple products, its primary revenue driver Eylea is facing several competitive threats. 4. Oracle (ORCL) downgraded to Neutral from Outperform at Macquarie with analyst Sarah Hindlian telling investors that her checks suggest that closing the fourth quarter "was a struggle," with partners saying they had to rush to discount orders up until the final days. 5. J.B. Hunt (JBHT) downgraded to Neutral from Buy at UBS with analyst Thomas Wadewitz citing his increasing conviction that after a period of strong freight and unusually strong pricing in 2018, the downturn in freight will persist through 2019 amid "falling truckload and intermodal contract rates" for 2020. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/18/19
06/18/19
DOWNGRADE

Hold
Regeneron downgraded to Hold at Argus on mounting threats to Eylea
As previously reported, Argus analyst Jasper Hellweg downgraded Regeneron (REGN) to Hold from Buy, saying that while the company has a "strong pipeline" with new recent indications for multiple products, its primary revenue driver Eylea is facing several competitive threats. The analyst notes that Novartis (NVS) could launch a biologic designed to treat Eylea's key indication of wet age-related macular degeneration by the end of Q2 and also notes that the drug's patents are set to expire in 2022 in China and Japan, 2023 in the U.S., and 2024 in Europe. Hellweg adds that he will return his Regeneron rating to Buy if the company demonstrates that it can offset the impact of reduced Eylea sales, which accounted for over 75% of total revenue in Q1.

TODAY'S FREE FLY STORIES

02:50
07/16/19
07/16
02:50
07/16/19
02:50
General news
FX Update: The main dollar pairings have been trading in narrow ranges, »

FX Update: The main…

RACE

Ferrari

$168.55

2.05 (1.23%)

21:17
07/15/19
07/15
21:17
07/15/19
21:17
Recommendations
Ferrari analyst commentary at Goldman Sachs »

Ferrari price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNLSY

Renault

$0.00

(0.00%)

21:12
07/15/19
07/15
21:12
07/15/19
21:12
Initiation
Renault initiated at Goldman Sachs »

Renault initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PUGOY

Peugeot

$0.00

(0.00%)

21:07
07/15/19
07/15
21:07
07/15/19
21:07
Initiation
Peugeot initiated at Goldman Sachs »

Peugeot initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTES

NetEase

$256.35

-3.62 (-1.39%)

21:02
07/15/19
07/15
21:02
07/15/19
21:02
Hot Stocks
NetEase acquires minority stake in Behaviour Interactive, terms not stated »

NetEase Games announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$14.18

0.045 (0.32%)

20:57
07/15/19
07/15
20:57
07/15/19
20:57
Initiation
Fiat Chrysler initiated at Goldman Sachs »

Fiat Chrysler initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

DDAIF

Daimler AG

$0.00

(0.00%)

20:53
07/15/19
07/15
20:53
07/15/19
20:53
Initiation
Daimler AG initiated at Goldman Sachs »

Daimler AG initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMWYY

BMW

$0.00

(0.00%)

20:48
07/15/19
07/15
20:48
07/15/19
20:48
Initiation
BMW initiated at Goldman Sachs »

BMW initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

$13.99

0.175 (1.27%)

20:38
07/15/19
07/15
20:38
07/15/19
20:38
Periodicals
Vale to pay $106.5M to Brazil workers impacted by dam incident, Reuters says »

Vale disclosed that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

RNR

RenaissanceRe

$187.35

3.295 (1.79%)

20:36
07/15/19
07/15
20:36
07/15/19
20:36
Downgrade
RenaissanceRe rating change at Deutsche Bank »

RenaissanceRe downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

JPM

JPMorgan

$113.87

-1.45 (-1.26%)

, JNJ

Johnson & Johnson

$134.67

0.38 (0.28%)

20:25
07/15/19
07/15
20:25
07/15/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JPM

JPMorgan

$113.87

-1.45 (-1.26%)

JNJ

Johnson & Johnson

$134.67

0.38 (0.28%)

WFC

Wells Fargo

$46.70

-0.65 (-1.37%)

GS

Goldman Sachs

$211.55

-2.4 (-1.12%)

PLD

Prologis

$79.94

-0.09 (-0.11%)

FRC

First Republic

$98.61

-2.02 (-2.01%)

DPZ

Domino's Pizza

$269.97

-12.26 (-4.34%)

SNV

Synovus

$34.35

-1.08 (-3.05%)

FHN

First Horizon

$14.80

-0.305 (-2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 29

    Jul

  • 30

    Jul

  • 06

    Aug

  • 27

    Aug

  • 28

    Aug

  • 06

    Sep

  • 09

    Sep

  • 16

    Sep

  • 23

    Sep

  • 12

    Oct

  • 13

    Nov

SON

Sonoco

$64.49

-0.69 (-1.06%)

20:04
07/15/19
07/15
20:04
07/15/19
20:04
Downgrade
Sonoco rating change at BMO Capital »

Sonoco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

  • 17

    Oct

SON

Sonoco

$64.49

-0.69 (-1.06%)

19:59
07/15/19
07/15
19:59
07/15/19
19:59
Downgrade
Sonoco rating change at BMO Capital »

Sonoco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

  • 17

    Oct

PLD

Prologis

$79.94

-0.09 (-0.11%)

19:51
07/15/19
07/15
19:51
07/15/19
19:51
Hot Stocks
Prologis to buy Black Creek Group industrial RE investment platform for $3.99B »

Black Creek Group has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

PLD

Prologis

$79.94

-0.09 (-0.11%)

19:48
07/15/19
07/15
19:48
07/15/19
19:48
Earnings
Prologis reports Q2 FFO 77c, consensus 76c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

CVX

Chevron

$125.71

-0.27 (-0.21%)

19:46
07/15/19
07/15
19:46
07/15/19
19:46
Hot Stocks
Chevron ordered to stop oil spill in California by State Regulator »

California Natural…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

GPL

Great Panther Silver

$0.72

-0.0409 (-5.38%)

19:33
07/15/19
07/15
19:33
07/15/19
19:33
Hot Stocks
Great Panther Silver names Jeffrey Mason as new board chair »

Great Panther Silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$120.88

0.77 (0.64%)

19:04
07/15/19
07/15
19:04
07/15/19
19:04
Hot Stocks
PayPal launches international money transfer service Xoom »

PayPal launched Xoom-its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

JBHT

J.B. Hunt

$92.50

-0.45 (-0.48%)

, EYEN

Eyenovia

$2.89

0.04 (1.40%)

18:58
07/15/19
07/15
18:58
07/15/19
18:58
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: JB…

JBHT

J.B. Hunt

$92.50

-0.45 (-0.48%)

EYEN

Eyenovia

$2.89

0.04 (1.40%)

VKTX

Viking Therapeutics

$8.25

0.02 (0.24%)

ARW

Arrow Electronics

$68.82

-0.15 (-0.22%)

ATEX

Anterix

$47.61

0.61 (1.30%)

RGEN

Repligen

$85.87

0.86 (1.01%)

MPW

Medical Properties Trust

$18.28

-0.23 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 24

    Jul

  • 25

    Jul

  • 06

    Aug

  • 08

    Aug

  • 09

    Aug

  • 26

    Aug

  • 09

    Sep

  • 18

    Sep

  • 19

    Sep

  • 13

    Nov

  • 16

    Jul

  • 17

    Jul

  • 17

    Jul

WTFC

Wintrust Financial

$69.99

-2.05 (-2.85%)

18:56
07/15/19
07/15
18:56
07/15/19
18:56
Earnings
Wintrust Financial reports Q2 EPS $1.38, consensus $1.66 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 06

    Aug

DDAIF

Daimler AG

$0.00

(0.00%)

18:46
07/15/19
07/15
18:46
07/15/19
18:46
Initiation
Daimler AG initiated at Goldman Sachs »

Daimler AG initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PUGOY

Peugeot

$0.00

(0.00%)

18:46
07/15/19
07/15
18:46
07/15/19
18:46
Initiation
Peugeot initiated at Goldman Sachs »

Peugeot initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$14.18

0.045 (0.32%)

18:45
07/15/19
07/15
18:45
07/15/19
18:45
Initiation
Fiat Chrysler initiated at Goldman Sachs »

Fiat Chrysler initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

TGI

Triumph Group

$23.07

-0.22 (-0.94%)

18:42
07/15/19
07/15
18:42
07/15/19
18:42
Hot Stocks
Triumph Group selected by leading airline as MRO provider »

Triumph Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 31

    Jul

TRQ

Turquoise Hill

$1.07

-0.02 (-1.83%)

18:32
07/15/19
07/15
18:32
07/15/19
18:32
Hot Stocks
Turquoise Hill reports Q2 copper output 39.2KT, down 0.6% from last year »

Reports Q2 Gold output…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.